HOOKIPA Pharma Inc. Gains 38.95%
Thu, May 01, 2025 at 07:34 PM
HOOKIPA Pharma Inc. (HOOK:NASDAQ) jumped higher at $1.32, a gain of 38.9%. On Thu, May 01, 2025, HOOK:NASDAQ hit a New 2-Week High of $1.32. The stock got featured on our News Catalysts scanner on Sat, Apr 26, 2025 at 01:15 AM in the 'BIOTECH' category. From Thu, Apr 17, 2025, the stock recorded 66.67% Up Days and 40.00% Green Days
About HOOKIPA Pharma Inc. (HOOK:NASDAQ)
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Top 10 Gainers:
- Classover Holdings Inc. (KIDZ:NASDAQ), 366.09%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 153.07%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 49.44%
- Society Pass Incorporated (SOPA:NASDAQ), 42.86%
- HOOKIPA Pharma Inc. (HOOK:NASDAQ), 38.95%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 38.71%
- BloomZ Inc. (BLMZ:NASDAQ), 37.75%
- Above Food Ingredients Inc. (ABVE:NASDAQ), 36.42%
- TNL Mediagene (TNMG:NASDAQ), 36.2%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 28.33%